The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample

Gene

Volumn 528, Issue 2, 2013, Pages 320-327

  Pazvantoǧlu, Ozan ^a   Güneş, Sezgin ^a   Karabekiroǧlu, Koray ^a   Yeǧin, Zeynep ^a   Erenkuş, Zehra ^b   Akbaş, Seher ^a   Sarisoy, Gökhan ^a   Korkmaz, Işil Zabun ^a   Böke, Ömer ^a   Baǧci, Hasan ^a   Şahin, Ahmet Rifat ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

5 HT2A gene; Genetics of ADHD; NET1 gene; SNAP 25 gene

Indexed keywords

CATECHOL METHYLTRANSFERASE; NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR 3; NORADRENALIN TRANSPORTER; NORADRENALIN TRANSPORTER 1; SEROTONIN 2A RECEPTOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTINOMIAL LOGIT MODEL; NORADRENERGIC SYSTEM; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; TURKEY (REPUBLIC);

5-HT2; 5-HT2A GENE; ADHD; ASRS; ATTENTION-DEFICIT HYPERACTIVITY DISORDER; CATECHOL-O-METHYL-TRANSFERASE; CATECHOL-O-METHYL-TRANSFERASE GENE; COMT; COMT GENE; CSS; DSM-IV; GENETICS OF ADHD; NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION; NCBI; NE; NET1 GENE; NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR-3 GENE; NOREPINEPHRINE; NOREPINEPHRINE TRANSPORTER GENE; NTF; NTF3 GENE; PCR; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RFLP; SCID; SELECTIVE SEROTONIN 2A RECEPTOR GENE; SEROTONIN; SINGLE NUCLEOTIDE POLYMORPHISM; SNAP-25; SNAP-25 GENE; SNP; STRUCTURED CLINICAL INTERVIEW FOR THE DSM-IV; SYNAPTOSOMAL-ASSOCIATED PROTEIN-25; SYNAPTOSOMAL-ASSOCIATED PROTEIN-25 GENE; THE ADULT ADHD SELF-REPORT SCALE; THE CURRENT SYMPTOM SCALE; THE DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FOURTH EDITION; THE WENDER-UTAH RATING SCALE-25; WURS-25;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; ONCOGENE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; RISK FACTORS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TURKEY; YOUNG ADULT;

EID: 84883049857     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.004     Document Type: Article

References (57)

1. Akutagava-Martins G.C., Salatino-Oliveira A., Kieling C.C., Rohde L.A., Hutz M.H. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert. Rev. Neurother. 2013, 13(4):435-445.
2. Aycicegi A., Dinn W.M., Harris C.L. Assessing adult attention deficit/hyperactivity disorder: a Turkish version of the current symptoms scale. Psychopathology 2003, 36(3):160-167.
3. Barkley R.A., Murphy K.R. Attention-deficit hyperactivity disorder. A Clinical Workbook 1998, Guilford Press, New York.
4. Barkley R.A., Murphy K.R., Fischer M. Identifying new symptoms for ADHD in adulthood. ADHD in Adults: What the Science Tells Us 2008, Guild Press, New York.
5. Biederman J., Faraone S.V., Keenan K., Knee D., Tsuang M.T. Family genetic and psychosocial risk factors in DSM-III attention deficit disorder. J. Am. Acad. Child Psy. 1990, 29(4):526-533.
6. Bobb A.J., et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 134B(1):67-72.
7. Brophy K., Hawi Z., Kirley A., Fitzgerald M., Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population. Mol. Psychiatry 2002, 7(8):913-917.
8. Brus R., Nowak P., Szkilnik R., Mikolajun U., Kostrzewa R.M. Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox. Res. 2004, 6(4):317-325.
9. Chang Z., Lichtenstein P., Asherson P.J., Larsson H. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry 2013, 70(3):311-318.
10. Cho S.C., et al. Neurotrophin-3 gene, intelligence, and selective attention deficit in a Korean sample with attention-deficit/hyperactivity disorder. Prog. neuro-Psychopharmacol. 2010, 34(6):1065-1069.
11. Chronis A.M., Lahey B.B., Pelham W.E., Kipp H.L., Baumann B.L., Lee S.S. Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Psychol. 2003, 42(12):1424-1432.
12. Conner A.C., et al. Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(8):1476-1480.
13. Çorapçioǧlu A. Turkish Version of Structured Clinical Interview for the DSM-IV-TR (SCID-I) 1999, HYB, Ankara.
14. De Luca V., Muglia P., Jain U., Kennedy J.L. No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 124B(1):38-40.
15. Doǧan S., Öncü B., Saraçoǧlu G.V., Kücükgöncü S. Adult attention deficit hyperactivity disorder self-report scale (ASRS-v1.1): the validity and reliability of Turkish version. Anatol. J. Psychiatry 2009, 10(2):77-87.
16. Elia J., et al. Attention-deficit/hyperactivity disorder genomics: update for clinicians. Curr. Psychiatry Rep. 2012, 14(5):579-589.
17. Faraone S.V., Biederman J. Nature, nurture, and attention deficit hyperactivity disorder. Dev. Rev. 2000, 20(4):568-581.
18. Faraone S.V., Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatry Clin. N. Am. 2010, 33(1):159-180.
19. Faraone S.V., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57(11):1313-1323.
20. Feng Y., et al. The SNAP-25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol. Psychiatry 2005, 10(11):998-1005.
21. Forero D.A., Arboleda G.H., Vasquez R., Arboleda H. Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants. J. Psychiatry Neurosci. 2009, 34(5):361-366.
22. Franke B., et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol. Psychiatry 2012, 17(10):960-987.
23. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 2009, 126(1):51-90.
24. Guimaraes A.P., et al. Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(1):69-73.
25. Halleland H., Lundervold A.J., Halmøy A., Haavik J., Johansson S. Association between catechol-O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(3):403-410.
26. Hawi Z., et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry 2002, 7(7):718-725.
27. Hinney A., et al. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156B(8):888-897.
28. Ho A.M., Tang N.L., Cheung B.K., Stadlin A. Dopamine receptor D4 gene-521C/T polymorphism is associated with opioid dependence through cold-pain responses. Ann. N. Y. Acad. Sci. 2008, 1139:20-26.
29. Joung Y., et al. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(2):691-694.
30. Kessler R.C., et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol. Med. 2005, 35(2):245-256.
31. Kuntsi J., Rijsdijk F., Ronald A., Asherson P., Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol. Psychiatry 2005, 57(6):647-654.
32. Kustanovich V., Merriman B., McGough J., McCracken J.T., Smalley S.L., Nelson S.F. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol. Psychiatry 2003, 8(3):309-315.
33. Lempp T., et al. Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40(10):221-228.
34. Li J., et al. Contribution of 5-HT2A receptor gene-1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B(5):473-476.
35. Mahomedy Z., et al. Persistence of attention deficit/hyperactivity disorder into adulthood: a study conducted on parents of children diagnosed with attention deficit/hyperactivity disorder. South African Psychiatry Review 2007, 10:93-98.
36. Mill J., Richards S., Knight J., Curran S., Taylor E., Asherson P. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol. Psychiatry 2004, 9(8):801-810.
37. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
38. Müller D., et al. Serotonin transporter gene and adverse life events in adult ADHD. Am. J. Med.Genet. B Neuropsychiatr. Genet. 2008, 147(B(8)):1461-1469.
39. Musil R., et al. SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J. Psychiatr. Res. 2008, 42(12):963-970.
40. Öncu B., Günay Ş., Şentürk V. Validity and reliability of the Turkish version of the Wender Utah rating scale for attention-deficit/hyperactivity disorder in adults. Turk. J. Psychiatry 2005, 16(4):252-259.
41. Parsons M.J., D'Souza U.M., Arranz M.J., Kerwin R.W., Makoff A.J. The -1438 A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol. Psychiatry 2004, 56(6):406-410.
42. Retz W., et al. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J. Neural Transm. 2008, 115(2):323-329.
43. Ribasés M., et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention deficit/hyperactivity disorder. Biol. Psychiatry 2008, 63(10):935-945.
44. Ribasés M., et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A. DDC and MAOB. Mol. Psychiatry 2009, 14(1):71-85.
45. Sarkar K., et al. Role of SNAP-25 explored in eastern Indian attention deficit hyperactivity disorder probands. Neurochem. Res. 2012, 37(2):349-357.
46. Simon V., Czobor P., Balint S., Mészáros A., Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br. J. Psychiatry 2009, 194:204-211.
47. Sollner T., et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993, 25(362):318-324.
48. Sprich S., Biederman J., Crawford M.H., Mundy E., Faraone S.V. Adoptive and biological of children and adolescent with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(11):1432-1437.
49. Syed Z., Dudbridge F., Kent L. An investigation of the neurotrophic factor genes BDNF, NGF, and NT3 in susceptibility to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(3):375-378.
50. Tander B., et al. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol. Int. 2008, 28(7):685-691.
51. Thapar A., Cooper M., Jefferies R., Stergiakouli E. What causes attention deficit hyperactivity disorder?. Arch. Dis. Child. 2012, 97(3):260-265.
52. Thapar A., Cooper M., Eyre O., Kate Langley K. Practitioner review: what have we learnt about the causes of ADHD?. J. Child Psychol. and Psyc. 2013, 54(1):3-16.
53. Wallis D., Russell H.F., Muenke M. Review: genetics of attention deficit hyperactivity disorder. J. Pediatr. Psychol. 2008, 33(10):1085-1099.
54. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am. J. Psychiatry 1993, 1(50):885-890.
55. Xu X., Mill J., Chen C.K., Brookes K., Taylor E., Asherson P. Family-based association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder: no evidence for association in UK and Taiwanese samples. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B(1):11-13.
56. Xu X., et al. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(8):1564-1567.
57. Zoroglu S.S., Erdal M.E., Erdal N., Ozen S., Alasehirli B., Sivasli E. No evidence for an association between the T102C and 1438G/A polymorphisms of the serotonin receptor gene in attention deficit/hyperactivity disorder in a Turkish population. Neuropsychobiology 2003, 47(1):17-20.